Sunbeam Capital Management’s Boston Scientific BSX Stock Holding History

Sunbeam Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,106	Closed	-$296K	–	113
2025 Q4	$296K	Buy	3,106 +16	+0.5%	+$1.57K	0.18%	81
2025 Q3	$302K	Hold	3,090	–	–	0.19%	74
2025 Q2	$332K	Hold	3,090	–	–	0.25%	62
2025 Q1	$312K	Hold	3,090	–	–	0.3%	57
2024 Q4	$276K	Buy	+3,090	New	+$272K	0.26%	66

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sunbeam Capital Management's BSX Position: Q1 2026 in Review

Sunbeam Capital Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 3,106 shares — an estimated $296K sold.

Sunbeam Capital Management first reported a position in BSX in Q4 2024 and held it in 5 quarters. The position peaked at $332K in Q2 2025. 1,667 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Sunbeam Capital Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Sunbeam Capital Management sold 3,106 Boston Scientific shares in Q1 2026, an estimated $296K.
Sunbeam Capital Management first reported a position in Boston Scientific in Q4 2024 and held it in 5 quarters.
Sunbeam Capital Management's Boston Scientific position peaked at $332K in Q2 2025.
1,667 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Sunbeam Capital Management's 13F filing for Q1 2026, filed 16 Apr 2026.